Prytime Medical announces the launch of the PROMPT Observational Clinical Trial, the first prospective in-human study of Partial REBOA
The PROMPT Study will give the trauma community the most compelling data yet on where Partial REBOA using pREBOA-PRO will fit in their toolkit to improve patient outcomes and save lives.